Data
Versioned dataset inventories, provenance, split definitions, integrity checks and explicit source, target and independent-validation roles.
BioNuclei is organized as an inspectable chain from data and model computation through cross-domain evaluation, robustness analysis and retained evidence. This page describes that research structure rather than the separate MCP ecosystem.
Each part has a defined role in the evidence chain. The architecture is a way to organize the research, not a substitute for experimental evidence.
Versioned dataset inventories, provenance, split definitions, integrity checks and explicit source, target and independent-validation roles.
The scientific model is evaluated as part of a controlled pipeline, with configuration and execution records retained alongside results.
Cross-domain transfer, failure analysis, controlled robustness experiments and prespecified statistical evaluation test what changes when the image domain changes.
Artifacts, metrics, configurations, manifests and verification records provide the traceability needed to inspect each scientific claim.
The research pipeline can be read as explicit stages, with each handoff preserving the information required for reproducibility and audit.
Record declared images, labels, versions and acquisition provenance.
Keep source training, target evaluation and independent validation roles explicit.
Run the declared segmentation configuration without silently changing the protocol.
Measure transfer behavior on declared evaluation populations.
Characterize where robustness breaks rather than reporting only aggregate performance.
Preserve metrics, parameters, artifacts and verification records for inspection.
BioNuclei's research architecture separates the scientific experiment from future interoperability layers. Models and scientific software perform the analysis; later MCP components may provide interfaces around established capabilities.
Dataset handling, segmentation, evaluation, robustness analysis, statistics and evidence generation belong to the research programme.
BioMCP and related MCP directions are separate future interfaces for coordinating established scientific capabilities. They are not the scientific foundation of BioNuclei.
The website keeps the boundary explicit: datasets, research and scientific architecture belong to BioNuclei; BioMCP, BioFM, BioWF and BioSkills are presented separately as future interoperability and ecosystem directions.